Hyperfractionated accelerated radiation therapy for nonsmall cell lung cancer: Clinical phase I/II trial

International Journal of Radiation Oncology Biology Physics

Volumn 39, Issue 3, 1997, Pages 545-552

  Fu, Xiao Long ^a   Jiang, Guo Liang ^a   Wang, Li Juan ^a   Qian, Hao ^a   Fu, Sen ^a   Yie, Ming ^a   Kong, Feng Ming ^a   Zhao, Sen ^a   He, Shao Qin ^a   Liu, Tai Fu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Accelerated irradiation; Accelerated proliferation; Hyperfractionated accelerated irradiation; Hyperfractionated irradiation; Nonsmall cell lung caner; Radiotherapy

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGITIS; FEMALE; HUMAN; LARGE CELL CARCINOMA; LUNG FIBROSIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; RADIATION INJURIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0030884537     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00332-5     Document Type: Article

References (9)

1. Cox, J. D.; Azarnio, N.; Byhardt, R. W.; Shin, K. H.; Emami, B.; Pajak, T. F. A randomized phase I/II trial of hyperfractionated radiation therapy with total dose of 60.0 Gy to 79.2 Gy: Possible survival benefit with ≥69.6 Gy in favorable patients with RTOG stage III non small cell lung cancer: Report of RTOG 83-11. J. Clin. Oncol. 8:1543-1555; 1990.
2. Fletcher, G. H. Clinical dose-response curves of human malignant epithelial tumors. Br. J. Radiol. 46:1-12, 1973.
3. Fu, S.; Jiang, G. L.; Wang, L. J.; Qi, H.; Kong, F. M.; Xia, C. J. Hyperfractionated irradiation for non small cell lung cancer. Clin. J. Oncol. 16:306-309; 1994.
4. Graham, M. V. Three dimensional radiotherapy for non-small cell lung cancer. The Washington University experience (Abstr). 2nd International Symposium on 3 D-radiation treatment planning and conformal therapy. St. Louis, MO, Apr. 11-13, 1996.
5. Herskovic, A.; Orton, C.; Seyedsadr, M.; Lattin, P.; Kraut, M.; Han, I.; Han, S.; Ahmad, K.; Holt, J. Initial experience with practical hyperfractionated accelerated radiation therapy regimen. Int. J. Radiat. Oncol. Biol. Phys. 21:1275-1281; 1991.
6. Herskovic, A.; Farnan, N; Demas, W; Gaspar, L; and Trotti, A. Tolerance and toxicity of T.I.D. accelerated hyperfractionated for bronchogenic cancer - RTOG 92-05 (Abstr). Int. J. Radiat. Oncol. Biol. Phys. 32(Suppl 1):278; 1995.
7. Leibel, S. A.; Armstrong, J. G.; Kutcher G. J.; Zelefsky, M. J.; Burman, C. M.; Mohan, R.; Ling, C. C.; Fuks, Z. 3-D conformal radiation therapy for non-small cell lung carcinoma. Clinical experience at the Memorial Sloan-Kettering Cancer Center. Front Radiat Ther Oncol 29:199-206; 1996.
8. Saunders, M. I.; Dische, S.; Grosch, E. J.; Fermont, D. C.; Ashford, R. F. U.; Maher, E. J.; Makepeace, A. R. Experience with CHART. Int. J. Radiat. Oncol. Biol. Phys. 21:871-878; 1991.
9. Saunders, M. I.; Dische, S.; Barrett, A.; Parmar, M. K.; Harvey, A.; Gibson, D. Randomized multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small cell lung cancer: An interim report. CHART Steering Committee. Br. J. Cancer 73:1455-1462; 1996.